Skip to main content
O

ORTHOCELL LIMITED — Investor Relations & Filings

Ticker · OCC ISIN · AU000000OCC6 ASX Manufacturing
Filings indexed 778 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country AU Australia
Listing ASX OCC

About ORTHOCELL LIMITED

https://orthocell.com/

Orthocell Limited is a regenerative medicine company focused on the development and commercialization of innovative technologies for the repair and regeneration of human soft tissue. The company’s core product portfolio includes the CelGro platform, a naturally derived collagen medical device designed to facilitate tissue repair and reconstruction in applications such as dental bone and soft tissue regeneration, nerve repair, and tendon repair. Orthocell also specializes in advanced cellular therapies, notably Ortho-ATI (Autologous Tenocyte Implantation) for treating chronic tendon injuries and Ortho-ACI (Autologous Chondrocyte Implantation) for cartilage repair. These therapies utilize a patient's own cells to restore function and structure to damaged tissues. The company aims to provide restorative solutions that improve clinical outcomes and offer alternatives to traditional surgical interventions.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - OCC 8 pages 21.5KB
Regulatory Filings
2026-05-04 English
Cleansing Notice 2 pages 597.7KB
Regulatory Filings
2026-05-04 English
Appendix 3Y - John Van Der Wielen 2 pages 220.0KB
Regulatory Filings
2026-05-03 English
Appendix 3Y - Michael McNulty 2 pages 219.8KB
Regulatory Filings
2026-05-03 English
First Sales of Remplir Achieved in US$75m Canadian Market 3 pages 595.0KB
Regulatory Filings
2026-04-29 English
Compelling 90% Success Rate for Remplir in Real World Study 4 pages 610.6KB
Regulatory Filings Classification · 85% confidence The document is an ASX announcement presenting clinical study results (real-world evidence) for the company’s Remplir™ product. It is a press release style regulatory announcement rather than an earnings release, financial report, meeting materials, or other specific filing type. It does not contain full financials or formal meeting documentation. Therefore, it falls into the general regulatory announcements category (RNS).
2026-04-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.